Case Based Peer Perspectives

Kevin Kalinsky, MD, MS, provides guidance on treating a patient with HR-positive breast cancer with a CDK4/6 inhibitor, and recommends management strategies for patients who develop relapsed disease.

Chirag A. Shah, MD, discusses the management of an ovarian cancer case and highlights potential treatment options and importance of use of maintenance therapy.

Dan Petrylak, MD, discusses 2 case studies that focus on metastatic castration-sensitive prostate cancer, with emphasis on the use of abiraterone to treat the disease.

Expert oncologist Bobby Liaw, MD, reviews a case of metastatic castration-sensitive prostate cancer and reflects on the optimal treatment approach and management.

John Allan, MD, reviews the diagnosis and treatment of a 67-year-old man with chronic lymphocytic leukemia while highlighting potential treatment options.

Doctor Daniel Greenwald reflects on decisions to treat a woman with newly diagnosed follicular lymphoma with obinutuzumab-based immunochemotherapy and maintenance therapy.

City of Hope’s Dr Afsaneh Barzi reacts to how an elderly man with metastatic cholangiocarcinoma was treated through multiple lines of therapy and provides recommendations on the appropriate management of the disease in similar scenarios.

Expert oncologist Milind Javle, MD, reflects on the optimal diagnosis and management of metastatic cholangiocarcinoma in the context of a hypothetical patient case.

Matthew R. Smith, MD, PhD reviews treatment options and management of patients with metastatic castration-resistant prostate cancer (mCRPC).

Tomasz M. Beer, MD, FACP, reviews key clinical trial data and treatment options for the management of metastatic castration-resistant prostate cancer (mCRPC).

Alan Skarbnik, MD, reviews the case of a 60-year-old man with follicular lymphoma and provides a discussion on treatment considerations and challenges.

Alicia Morgans, MD, MPH provides insight on the treatment of mCRPC with lutetium-177-PSMA-617 in recurrent setting.

Kanwal Raghav, MBBS, MD, discusses the case of a 72-year-old woman with metastatic colorectal cancer and explains the possible therapy options.

Tanios Bekaii-Saab, MD, FACP, presents a case study involving a 65-year-old patient diagnosed with stage 4 metastatic colorectal cancer and provides an in-depth discussion on the most effective therapy options for the disease.

Lyndsay Willmott, MD, discusses the case of a 57-year-old woman with ovarian cancer and the available treatment options.

Dr Ramez Eskander, an expert gynecologist oncologist, reviews the case of a 64-year-old woman with advanced ovarian cancer.

Expert perspectives on the optimal management of a woman who is diagnosed and relapses with diffuse large B-cell lymphoma.

Perry Cook, MD, reviews the case of a 76-year-old man with relapsed/refractory follicular lymphoma and provides a discussion on treatment considerations and challenges.

Pierre Gholam, MD, reviews significant clinical trial data and treatment options for the management of unresectable HCC.

Laurie Sehn, MD, presents the case of a 76-year-old man with relapsed diffuse B-cell lymphoma and highlights the treatment options available to patients.

Andrew Zelenetz, MD, reviews the diagnosis and treatment plan for a 77-year-old man with relapsed chronic lymphocytic leukemia (CLL) while highlighting several treatment options.

An expert in hematology oncology, Jeff Sharman, MD, reviews the case of a 73-year-old woman with chronic lymphocytic leukemia (CLL) and shares key insights into factors to consider when selecting first- and second-line treatment.

Ghassan K. Abou-Alfa, MD, MBA, reviews key clinical trial data and treatment options for the management of unresectable HCC.

Thought leader in thoracic oncology, Hossein Borghaei, DO, reviews the case of a 59-year-old man with extensive-stage small-cell lung cancer and discusses the current treatment landscape by highlighting key clinical trial data on the safety and efficacy of lurbinectedin.

Loretta Nastoupil, MD, provides insights into the contemporary and future treatment options for a patient with relapsed/refractory follicular lymphoma (R/R FL).

Thought leader in thoracic oncology, Jared Weiss, MD, reviews the case of a 64-year-old woman with extensive-stage small-cell lung cancer and discusses the current treatment landscape by highlighting key clinical trial data on the safety and efficacy of lurbinectedin.

John Marshall, MD, reviews the case of a patient with metastatic HER2+ (human epidermal growth factor receptor 2) cancer of the gastroesophageal junction.

John Burke, MD, reviews the case of a 76-year-old man with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) while analyzing current and future treatment options in R/R DLBCL.